Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Congratulations to the 2026 Editorial Fellows.

Radiology·2026
Same author

MHub.ai: A Standardized Platform for Reproducible AI Research in Medical Imaging.

Research square·2026
Same author

Critical role of keratinocytes and protease-activated receptor 2 in secondary lymphedema development.

Clinical and translational medicine·2026
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same journal

The Inverse Care Law in the Age of AI - Geographic Disparities in Health Care Technology Access.

NEJM AI·2026
Same journal

AI-Guided Surgical Blood Readiness: Overcoming Real-World Challenges in Prospective Validation for Safer, More Efficient Blood Preparation.

NEJM AI·2026
Same journal

Brain Health from Sleep EEG: A Multicohort, Deep Learning Biomarker for Cognition, Disease, and Mortality.

NEJM AI·2026
Same journal

Developing ICU Clinical Behavioral Atlas Using Ambient Intelligence and Computer Vision.

NEJM AI·2026
Same journal

A Case Study of AI-Enabled Software as a Medical Device Cleared by the FDA for Assessing Hemorrhage Risk Index (APPRAISE-HRI) after Trauma.

NEJM AI·2026
Same journal

Catalyzing Health AI by Fixing Payment Systems.

NEJM AI·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Automated Midline Shift and Intracranial Pressure Estimation based on Brain CT Images
14:08

Automated Midline Shift and Intracranial Pressure Estimation based on Brain CT Images

Published on: April 13, 2013

42.8K

Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep Learning.

Divyanshu Tak1,2, Biniam A Garomsa1,2, Anna Zapaishchykova1,2

  • 1Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.

NEJM AI
|June 19, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a temporal deep-learning model that significantly improves the prediction of pediatric glioma recurrence using serial MRI scans. The AI approach enhances risk assessment, potentially optimizing patient surveillance and care for brain tumors.

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.4K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.0K

Related Experiment Videos

Last Updated: Jun 13, 2026

Automated Midline Shift and Intracranial Pressure Estimation based on Brain CT Images
14:08

Automated Midline Shift and Intracranial Pressure Estimation based on Brain CT Images

Published on: April 13, 2013

42.8K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.4K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.0K

Area of Science:

  • Artificial Intelligence in Oncology
  • Medical Imaging Analysis
  • Pediatric Neuro-oncology

Background:

  • Pediatric glioma recurrence presents heterogeneous patterns, challenging prediction with current clinical and genomic markers.
  • Frequent, long-term MRI surveillance is standard for pediatric glioma patients due to unpredictable recurrence.
  • Limited data availability and existing machine learning methods have hindered progress in individualized recurrence prediction.

Purpose of the Study:

  • To develop and validate a deep-learning approach for improved prediction of pediatric glioma recurrence using longitudinal MRI data.
  • To enhance individualized risk assessment for pediatric glioma patients undergoing surveillance.
  • To explore the adaptability of temporal learning for other cancers and chronic diseases.

Main Methods:

  • Developed a self-supervised temporal deep-learning model for longitudinal medical imaging.
  • Model encodes serial MRI scans, trained on chronological order classification (pretext task).
  • Fine-tuned model for 1-year recurrence prediction in pediatric gliomas using historical surveillance scans from 715 patients (3994 scans).

Main Results:

  • Temporal learning improved recurrence prediction performance (F1 score) by up to 58.5% compared to traditional methods.
  • Performance gains were observed in both low- and high-grade pediatric gliomas, with AUC ranging from 75% to 89%.
  • Prediction accuracy improved with more historical scans, plateauing between three and six scans.

Conclusions:

  • Temporal deep learning offers high-performance longitudinal analysis for pediatric brain tumor surveillance and decision support.
  • This approach shows potential for broad application in tracking and predicting risk for other cancers and chronic diseases.
  • The AI model facilitates more precise, individualized patient management in neuro-oncology.